iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER All Issues Volume 4 Issue 4
Volume 4 Issue 4, December 2025
14 articles
|
Next Issue
Editorial
Editorial | Open Access
Recalibrating the evidence level in hepatocellular carcinoma: Integrating efficacy and effectiveness of immunotherapy
Published: 06 November 2025
2025, 4(4)
Editorial | Open Access
Personalized management of metabolic dysfunction-associated steatotic liver disease
Published: 13 November 2025
2025, 4(4)
Editorial | Open Access
Tumor microenvironment remodeling in pancreatic cancer liver metastasis
Published: 13 November 2025
2025, 4(4)
Review
Review | Open Access
Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage
Published: 13 September 2025
2025, 4(4)
Review | Open Access
From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management
Published: 25 October 2025
2025, 4(4)
Review | Open Access
Convergent systemic therapy for liver metastases: Bridging primary tumor heterogeneity through shared pathways
Published: 07 November 2025
2025, 4(4)
Review | Open Access
Artificial intelligence in hepatology: A comprehensive scoping review of clinical applications, challenges, and future directions
Published: 07 November 2025
2025, 4(4)
Original Article
Original Article | Open Access
Coagulation abnormalities in children with chronic liver disease and the association of these abnormalities with disease severity
Published: 05 November 2025
2025, 4(4)
Original Article | Open Access
Efficacy of Double Plasma Molecular Adsorption System combined with plasma exchange in improving survival outcomes of patients with acute hepatitis E-induced liver failure: A retrospective cohort analysis
Published: 05 November 2025
2025, 4(4)
Original Article | Open Access
Development and validation of an individualized online calculator for early mortality risk after hepatectomy among patients with hepatocellular carcinoma
Published: 10 November 2025
2025, 4(4)
Original Article | Open Access
Bile cell-free DNA shows benefit as a potential sample for somatic mutation detection of resectable cholangiocarcinoma
Published: 07 November 2025
2025, 4(4)
Commentary
Commentary | Open Access
DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma
Published: 01 November 2025
2025, 4(4)
Letters to Editor
Letters to Editor | Open Access
Immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: The critical role of subgroup analyses
Published: 11 November 2025
2025, 4(4)
Case Report
Case Report | Open Access
Recommendations for management of pregnancy complicated by Caroli disease: A case report and literature review
Published: 04 November 2025
2025, 4(4)